1255468

MAYNE PHARMA LLC — FEI 3016589167

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 17, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Raleigh, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)